Cargando…
Targeting of AKT1 by miR-143-3p Suppresses Epithelial-to-Mesenchymal Transition in Prostate Cancer
An altered expression of miR-143-3p has been previously reported in prostate cancer where it is purported to play a tumor suppressor role. Evidence from other cancers suggests miR-143-3p acts as an inhibitor of epithelial-to-mesenchymal transition (EMT), a key biological process required for metasta...
Autores principales: | Armstrong, Lee, Willoughby, Colin E., McKenna, Declan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526992/ https://www.ncbi.nlm.nih.gov/pubmed/37759434 http://dx.doi.org/10.3390/cells12182207 |
Ejemplares similares
-
Prognostic value of miR-21 for prostate cancer: a systematic review and meta-analysis
por: Stafford, M.Y. Cynthia, et al.
Publicado: (2022) -
Regulation of miR‐200c and miR‐141 by Methylation in Prostate Cancer
por: Lynch, Seodhna M., et al.
Publicado: (2016) -
The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease
por: Vacante, Francesca, et al.
Publicado: (2019) -
MiR-182 Is Upregulated in Prostate Cancer and Contributes to Tumor Progression by Targeting MITF
por: Stafford, M. Y. Cynthia, et al.
Publicado: (2023) -
Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1
por: Song, Li-na, et al.
Publicado: (2020)